arrow
X

Xavier Calvo

Hospital del Mar Research Institute
H指数:20
被引数:1,412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)—Proposal of the objective prognostic index for CMML (OPIC)
2026-01-280
OAAI
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE

比较治疗相关和原发性MDS的1590例与4738例患者预后变量和细胞遗传学异常的比较,包括MDS阶段治疗的影响

2025-09-010
PRE
Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements

MYC易位的边缘区起源克隆性B细胞淋巴细胞增生的基因组特征

2025-07-290
PRE
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
2024-03-180
OAAI
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
2023-09-042
OAAI
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia

多命中TET2突变作为寡单核细胞和明显的慢性粒细胞单核细胞白血病的差异分子特征

LEUKEMIA
IF13.4
2022-10-2210
PRE
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum

寡单核细胞CMML的结果和分子特征支持将其视为CMML连续体的第一阶段

2022-07-0615
OAAI
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
2021-03-1115
OAAI
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

与治疗相关的骨髓增生异常综合征应进行特定的诊断亚分类和风险分层-t-mds患者的分类方法

LEUKEMIA
IF13.4
2020-06-2958
OAAI
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma
2018-06-2824
OAAI